Asiatic Laboratories Limited (DSE: ASIATICLAB)

Asiatic Laboratories Income Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2022	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	1,473	1,473	1,451	1,326
Revenue Growth (YoY)	-	1.48%	9.42%	-
Cost of Revenue	835.39	835.39	827.88	756.23
Gross Profit	637.39	637.39	623.38	570.13
Selling, General & Admin	221.76	221.76	207.87	172.98
Operating Expenses	221.76	221.76	207.87	172.98
Operating Income	415.63	415.63	415.51	397.15
Interest Expense	-41.02	-41.02	-43.92	-51.38
Currency Exchange Gain (Loss)	1.41	1.41	0.27	0.16
Other Non Operating Income (Expenses)	-0.26	-0.26	-0.38	-0.34
Pretax Income	375.76	375.76	371.48	345.59
Income Tax Expense	107.2	107.2	50.95	103.14
Net Income	268.56	268.56	320.52	242.45
Net Income to Common	268.56	268.56	320.52	242.45
Net Income Growth	-	-16.21%	32.20%	-
Shares Outstanding (Basic)	88	88	88	88
Shares Outstanding (Diluted)	88	88	88	88
EPS (Basic)	3.06	3.06	3.65	2.76
EPS (Diluted)	3.06	3.06	3.65	2.76
EPS Growth	-	-16.21%	32.20%	-
Free Cash Flow	-	-	56.91	159.27
Free Cash Flow Per Share	-	-	0.65	1.81
Gross Margin	43.28%	43.28%	42.95%	42.98%
Operating Margin	28.22%	28.22%	28.63%	29.94%
Profit Margin	18.23%	18.23%	22.09%	18.28%
Free Cash Flow Margin	-	-	3.92%	12.01%
EBITDA	504.82	504.82	504.7	475.9
EBITDA Margin	34.28%	34.28%	34.78%	35.88%
D&A For EBITDA	89.19	89.19	89.19	78.75
EBIT	415.63	415.63	415.51	397.15
EBIT Margin	28.22%	28.22%	28.63%	29.94%
Effective Tax Rate	28.53%	28.53%	13.72%	29.84%
Advertising Expenses	7.36	7.36	6.11	5.26

Source: S&P Capital IQ. Standard template. Financial Sources.